Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Prescription Dermatological Drug market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Prescription Dermatological Drug market. Detailed analysis of key players, along with key growth strategies adopted by Prescription Dermatological Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Pfizer, Inc
Galderma SA.
Mylan Pharmaceuticals, Inc,
Allergan Inc.
PharmaDerm Pharmaceuticals, Inc.
Merck & Company, Inc
Collagenex (now Galderma) Pharmaceuticals
Medicis Pharmaceutical Corporation.
Galderma S.A.
Allergan Inamed Corporation
Nycomed Inc
GlaxoSmithKline Plc
Barrier Therapeutics, Inc.
Novartis Pharmaceuticals Corporation
Genentech, Inc
Bristol-Myers Squibb
By Type:
Type 1
Type 2
Type 3
By End-User:
End-Users 1
End-Users 2
End-Users 3
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Prescription Dermatological Drug Market
-
1.3 Market Segment by Type
1.3.1 Japan Prescription Dermatological Drug Market Size and Growth Rate of Type 1 from 2014 to 2026
1.3.2 Japan Prescription Dermatological Drug Market Size and Growth Rate of Type 2 from 2014 to 2026
1.3.3 Japan Prescription Dermatological Drug Market Size and Growth Rate of Type 3 from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Prescription Dermatological Drug Market Size and Growth Rate of Application 1 from 2014 to 2026
1.4.2 Japan Prescription Dermatological Drug Market Size and Growth Rate of Application 2 from 2014 to 2026
1.4.3 Japan Prescription Dermatological Drug Market Size and Growth Rate of Application 3 from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Prescription Dermatological Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Prescription Dermatological Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Prescription Dermatological Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Prescription Dermatological Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Prescription Dermatological Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Prescription Dermatological Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Prescription Dermatological Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Prescription Dermatological Drug Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Prescription Dermatological Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Prescription Dermatological Drug by Major Types
3.4.1 Market Size and Growth Rate of Type 1
3.4.2 Market Size and Growth Rate of Type 2
3.4.3 Market Size and Growth Rate of Type 3
4 Segmentation of Prescription Dermatological Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Prescription Dermatological Drug by Major End-Users
4.4.1 Market Size and Growth Rate of Prescription Dermatological Drug in Application 1
4.4.2 Market Size and Growth Rate of Prescription Dermatological Drug in Application 2
4.4.3 Market Size and Growth Rate of Prescription Dermatological Drug in Application 3
5 Market Analysis by Regions
-
5.1 Japan Prescription Dermatological Drug Production Analysis by Regions
-
5.2 Japan Prescription Dermatological Drug Consumption Analysis by Regions
6 Hokkaido Prescription Dermatological Drug Landscape Analysis
-
6.1 Hokkaido Prescription Dermatological Drug Landscape Analysis by Major Types
-
6.2 Hokkaido Prescription Dermatological Drug Landscape Analysis by Major End-Users
7 Tohoku Prescription Dermatological Drug Landscape Analysis
-
7.1 Tohoku Prescription Dermatological Drug Landscape Analysis by Major Types
-
7.2 Tohoku Prescription Dermatological Drug Landscape Analysis by Major End-Users
8 Kanto Prescription Dermatological Drug Landscape Analysis
-
8.1 Kanto Prescription Dermatological Drug Landscape Analysis by Major Types
-
8.2 Kanto Prescription Dermatological Drug Landscape Analysis by Major End-Users
9 Chubu Prescription Dermatological Drug Landscape Analysis
-
9.1 Chubu Prescription Dermatological Drug Landscape Analysis by Major Types
-
9.2 Chubu Prescription Dermatological Drug Landscape Analysis by Major End-Users
10 Kinki Prescription Dermatological Drug Landscape Analysis
-
10.1 Kinki Prescription Dermatological Drug Landscape Analysis by Major Types
-
10.2 Kinki Prescription Dermatological Drug Landscape Analysis by Major End-Users
11 Chugoku Prescription Dermatological Drug Landscape Analysis
-
11.1 Chugoku Prescription Dermatological Drug Landscape Analysis by Major Types
-
11.2 Chugoku Prescription Dermatological Drug Landscape Analysis by Major End-Users
12 Shikoku Prescription Dermatological Drug Landscape Analysis
-
12.1 Shikoku Prescription Dermatological Drug Landscape Analysis by Major Types
-
12.2 Shikoku Prescription Dermatological Drug Landscape Analysis by Major End-Users
13 Kyushu Prescription Dermatological Drug Landscape Analysis
-
13.1 Kyushu Prescription Dermatological Drug Landscape Analysis by Major Types
-
13.2 Kyushu Prescription Dermatological Drug Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Pfizer, Inc
14.1.1 Pfizer, Inc Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Galderma SA.
14.2.1 Galderma SA. Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Mylan Pharmaceuticals, Inc,
14.3.1 Mylan Pharmaceuticals, Inc, Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Allergan Inc.
14.4.1 Allergan Inc. Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 PharmaDerm Pharmaceuticals, Inc.
14.5.1 PharmaDerm Pharmaceuticals, Inc. Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Merck & Company, Inc
14.6.1 Merck & Company, Inc Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Collagenex (now Galderma) Pharmaceuticals
14.7.1 Collagenex (now Galderma) Pharmaceuticals Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Medicis Pharmaceutical Corporation.
14.8.1 Medicis Pharmaceutical Corporation. Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Galderma S.A.
14.9.1 Galderma S.A. Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 Allergan Inamed Corporation
14.10.1 Allergan Inamed Corporation Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
14.11 Nycomed Inc
14.11.1 Nycomed Inc Company Profile and Recent Development
14.11.2 Market Performance
14.11.3 Product and Service Introduction
14.12 GlaxoSmithKline Plc
14.12.1 GlaxoSmithKline Plc Company Profile and Recent Development
14.12.2 Market Performance
14.12.3 Product and Service Introduction
14.13 Barrier Therapeutics, Inc.
14.13.1 Barrier Therapeutics, Inc. Company Profile and Recent Development
14.13.2 Market Performance
14.13.3 Product and Service Introduction
14.14 Novartis Pharmaceuticals Corporation
14.14.1 Novartis Pharmaceuticals Corporation Company Profile and Recent Development
14.14.2 Market Performance
14.14.3 Product and Service Introduction
14.15 Genentech, Inc
14.15.1 Genentech, Inc Company Profile and Recent Development
14.15.2 Market Performance
14.15.3 Product and Service Introduction
14.16 Bristol-Myers Squibb
14.16.1 Bristol-Myers Squibb Company Profile and Recent Development
14.16.2 Market Performance
14.16.3 Product and Service Introduction
The List of Tables and Figures (Totals 116 Figures and 189 Tables)
Figure Japan Prescription Dermatological Drug Market Size and Growth Rate of Type 1 from 2014 to 2026
Figure Japan Prescription Dermatological Drug Market Size and Growth Rate of Type 2 from 2014 to 2026
Figure Japan Prescription Dermatological Drug Market Size and Growth Rate of Type 3 from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Prescription Dermatological Drug Market Size and Growth Rate of Application 1 from 2014 to 2026
Figure Japan Prescription Dermatological Drug Market Size and Growth Rate of Application 2 from 2014 to 2026
Figure Japan Prescription Dermatological Drug Market Size and Growth Rate of Application 3 from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Prescription Dermatological Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Prescription Dermatological Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Prescription Dermatological Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Prescription Dermatological Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Prescription Dermatological Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Prescription Dermatological Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Prescription Dermatological Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Prescription Dermatological Drug Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Prescription Dermatological Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Prescription Dermatological Drug
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Prescription Dermatological Drug by Different Types from 2014 to 2026
-
Table Consumption Share of Prescription Dermatological Drug by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Type 1
Figure Market Size and Growth Rate of Type 2
Figure Market Size and Growth Rate of Type 3
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Prescription Dermatological Drug by Different End-Users from 2014 to 2026
-
Table Consumption Share of Prescription Dermatological Drug by Different End-Users from 2014 to 2026
Figure Japan Prescription Dermatological Drug Market Size and Growth Rate of Application 1 from 2014 to 2026
Figure Japan Prescription Dermatological Drug Market Size and Growth Rate of Application 2 from 2014 to 2026
Figure Japan Prescription Dermatological Drug Market Size and Growth Rate of Application 3 from 2014 to 2026
-
Table Japan Prescription Dermatological Drug Production by Regions
-
Table Japan Prescription Dermatological Drug Production Share by Regions
-
Figure Japan Prescription Dermatological Drug Production Share by Regions in 2014
-
Figure Japan Prescription Dermatological Drug Production Share by Regions in 2018
-
Figure Japan Prescription Dermatological Drug Production Share by Regions in 2026
-
Table Japan Prescription Dermatological Drug Consumption by Regions
-
Table Japan Prescription Dermatological Drug Consumption Share by Regions
-
Figure Japan Prescription Dermatological Drug Consumption Share by Regions in 2014
-
Figure Japan Prescription Dermatological Drug Consumption Share by Regions in 2018
-
Figure Japan Prescription Dermatological Drug Consumption Share by Regions in 2026
-
Table Hokkaido Prescription Dermatological Drug Consumption by Types from 2014 to 2026
-
Table Hokkaido Prescription Dermatological Drug Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Prescription Dermatological Drug Consumption Share by Types in 2014
-
Figure Hokkaido Prescription Dermatological Drug Consumption Share by Types in 2018
-
Figure Hokkaido Prescription Dermatological Drug Consumption Share by Types in 2026
-
Table Hokkaido Prescription Dermatological Drug Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Prescription Dermatological Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Prescription Dermatological Drug Consumption Share by End-Users in 2014
-
Figure Hokkaido Prescription Dermatological Drug Consumption Share by End-Users in 2018
-
Figure Hokkaido Prescription Dermatological Drug Consumption Share by End-Users in 2026
-
Table Tohoku Prescription Dermatological Drug Consumption by Types from 2014 to 2026
-
Table Tohoku Prescription Dermatological Drug Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Prescription Dermatological Drug Consumption Share by Types in 2014
-
Figure Tohoku Prescription Dermatological Drug Consumption Share by Types in 2018
-
Figure Tohoku Prescription Dermatological Drug Consumption Share by Types in 2026
-
Table Tohoku Prescription Dermatological Drug Consumption by End-Users from 2014 to 2026
-
Table Tohoku Prescription Dermatological Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Prescription Dermatological Drug Consumption Share by End-Users in 2014
-
Figure Tohoku Prescription Dermatological Drug Consumption Share by End-Users in 2018
-
Figure Tohoku Prescription Dermatological Drug Consumption Share by End-Users in 2026
-
Table Kanto Prescription Dermatological Drug Consumption by Types from 2014 to 2026
-
Table Kanto Prescription Dermatological Drug Consumption Share by Types from 2014 to 2026
-
Figure Kanto Prescription Dermatological Drug Consumption Share by Types in 2014
-
Figure Kanto Prescription Dermatological Drug Consumption Share by Types in 2018
-
Figure Kanto Prescription Dermatological Drug Consumption Share by Types in 2026
-
Table Kanto Prescription Dermatological Drug Consumption by End-Users from 2014 to 2026
-
Table Kanto Prescription Dermatological Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Prescription Dermatological Drug Consumption Share by End-Users in 2014
-
Figure Kanto Prescription Dermatological Drug Consumption Share by End-Users in 2018
-
Figure Kanto Prescription Dermatological Drug Consumption Share by End-Users in 2026
-
Table Chubu Prescription Dermatological Drug Consumption by Types from 2014 to 2026
-
Table Chubu Prescription Dermatological Drug Consumption Share by Types from 2014 to 2026
-
Figure Chubu Prescription Dermatological Drug Consumption Share by Types in 2014
-
Figure Chubu Prescription Dermatological Drug Consumption Share by Types in 2018
-
Figure Chubu Prescription Dermatological Drug Consumption Share by Types in 2026
-
Table Chubu Prescription Dermatological Drug Consumption by End-Users from 2014 to 2026
-
Table Chubu Prescription Dermatological Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Prescription Dermatological Drug Consumption Share by End-Users in 2014
-
Figure Chubu Prescription Dermatological Drug Consumption Share by End-Users in 2018
-
Figure Chubu Prescription Dermatological Drug Consumption Share by End-Users in 2026
-
Table Kinki Prescription Dermatological Drug Consumption by Types from 2014 to 2026
-
Table Kinki Prescription Dermatological Drug Consumption Share by Types from 2014 to 2026
-
Figure Kinki Prescription Dermatological Drug Consumption Share by Types in 2014
-
Figure Kinki Prescription Dermatological Drug Consumption Share by Types in 2018
-
Figure Kinki Prescription Dermatological Drug Consumption Share by Types in 2026
-
Table Kinki Prescription Dermatological Drug Consumption by End-Users from 2014 to 2026
-
Table Kinki Prescription Dermatological Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Prescription Dermatological Drug Consumption Share by End-Users in 2014
-
Figure Kinki Prescription Dermatological Drug Consumption Share by End-Users in 2018
-
Figure Kinki Prescription Dermatological Drug Consumption Share by End-Users in 2026
-
Table Chugoku Prescription Dermatological Drug Consumption by Types from 2014 to 2026
-
Table Chugoku Prescription Dermatological Drug Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Prescription Dermatological Drug Consumption Share by Types in 2014
-
Figure Chugoku Prescription Dermatological Drug Consumption Share by Types in 2018
-
Figure Chugoku Prescription Dermatological Drug Consumption Share by Types in 2026
-
Table Chugoku Prescription Dermatological Drug Consumption by End-Users from 2014 to 2026
-
Table Chugoku Prescription Dermatological Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Prescription Dermatological Drug Consumption Share by End-Users in 2014
-
Figure Chugoku Prescription Dermatological Drug Consumption Share by End-Users in 2018
-
Figure Chugoku Prescription Dermatological Drug Consumption Share by End-Users in 2026
-
Table Shikoku Prescription Dermatological Drug Consumption by Types from 2014 to 2026
-
Table Shikoku Prescription Dermatological Drug Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Prescription Dermatological Drug Consumption Share by Types in 2014
-
Figure Shikoku Prescription Dermatological Drug Consumption Share by Types in 2018
-
Figure Shikoku Prescription Dermatological Drug Consumption Share by Types in 2026
-
Table Shikoku Prescription Dermatological Drug Consumption by End-Users from 2014 to 2026
-
Table Shikoku Prescription Dermatological Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Prescription Dermatological Drug Consumption Share by End-Users in 2014
-
Figure Shikoku Prescription Dermatological Drug Consumption Share by End-Users in 2018
-
Figure Shikoku Prescription Dermatological Drug Consumption Share by End-Users in 2026
-
Table Kyushu Prescription Dermatological Drug Consumption by Types from 2014 to 2026
-
Table Kyushu Prescription Dermatological Drug Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Prescription Dermatological Drug Consumption Share by Types in 2014
-
Figure Kyushu Prescription Dermatological Drug Consumption Share by Types in 2018
-
Figure Kyushu Prescription Dermatological Drug Consumption Share by Types in 2026
-
Table Kyushu Prescription Dermatological Drug Consumption by End-Users from 2014 to 2026
-
Table Kyushu Prescription Dermatological Drug Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Prescription Dermatological Drug Consumption Share by End-Users in 2014
-
Figure Kyushu Prescription Dermatological Drug Consumption Share by End-Users in 2018
-
Figure Kyushu Prescription Dermatological Drug Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Pfizer, Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer, Inc
Figure Sales and Growth Rate Analysis of Pfizer, Inc
Figure Revenue and Market Share Analysis of Pfizer, Inc
Table Product and Service Introduction of Pfizer, Inc
Table Company Profile and Development Status of Galderma SA.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Galderma SA.
Figure Sales and Growth Rate Analysis of Galderma SA.
Figure Revenue and Market Share Analysis of Galderma SA.
Table Product and Service Introduction of Galderma SA.
Table Company Profile and Development Status of Mylan Pharmaceuticals, Inc,
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan Pharmaceuticals, Inc,
Figure Sales and Growth Rate Analysis of Mylan Pharmaceuticals, Inc,
Figure Revenue and Market Share Analysis of Mylan Pharmaceuticals, Inc,
Table Product and Service Introduction of Mylan Pharmaceuticals, Inc,
Table Company Profile and Development Status of Allergan Inc.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan Inc.
Figure Sales and Growth Rate Analysis of Allergan Inc.
Figure Revenue and Market Share Analysis of Allergan Inc.
Table Product and Service Introduction of Allergan Inc.
Table Company Profile and Development Status of PharmaDerm Pharmaceuticals, Inc.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of PharmaDerm Pharmaceuticals, Inc.
Figure Sales and Growth Rate Analysis of PharmaDerm Pharmaceuticals, Inc.
Figure Revenue and Market Share Analysis of PharmaDerm Pharmaceuticals, Inc.
Table Product and Service Introduction of PharmaDerm Pharmaceuticals, Inc.
Table Company Profile and Development Status of Merck & Company, Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Company, Inc
Figure Sales and Growth Rate Analysis of Merck & Company, Inc
Figure Revenue and Market Share Analysis of Merck & Company, Inc
Table Product and Service Introduction of Merck & Company, Inc
Table Company Profile and Development Status of Collagenex (now Galderma) Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Collagenex (now Galderma) Pharmaceuticals
Figure Sales and Growth Rate Analysis of Collagenex (now Galderma) Pharmaceuticals
Figure Revenue and Market Share Analysis of Collagenex (now Galderma) Pharmaceuticals
Table Product and Service Introduction of Collagenex (now Galderma) Pharmaceuticals
Table Company Profile and Development Status of Medicis Pharmaceutical Corporation.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Medicis Pharmaceutical Corporation.
Figure Sales and Growth Rate Analysis of Medicis Pharmaceutical Corporation.
Figure Revenue and Market Share Analysis of Medicis Pharmaceutical Corporation.
Table Product and Service Introduction of Medicis Pharmaceutical Corporation.
Table Company Profile and Development Status of Galderma S.A.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Galderma S.A.
Figure Sales and Growth Rate Analysis of Galderma S.A.
Figure Revenue and Market Share Analysis of Galderma S.A.
Table Product and Service Introduction of Galderma S.A.
Table Company Profile and Development Status of Allergan Inamed Corporation
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan Inamed Corporation
Figure Sales and Growth Rate Analysis of Allergan Inamed Corporation
Figure Revenue and Market Share Analysis of Allergan Inamed Corporation
Table Product and Service Introduction of Allergan Inamed Corporation
Table Company Profile and Development Status of Nycomed Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nycomed Inc
Figure Sales and Growth Rate Analysis of Nycomed Inc
Figure Revenue and Market Share Analysis of Nycomed Inc
Table Product and Service Introduction of Nycomed Inc
Table Company Profile and Development Status of GlaxoSmithKline Plc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline Plc
Figure Sales and Growth Rate Analysis of GlaxoSmithKline Plc
Figure Revenue and Market Share Analysis of GlaxoSmithKline Plc
Table Product and Service Introduction of GlaxoSmithKline Plc
Table Company Profile and Development Status of Barrier Therapeutics, Inc.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Barrier Therapeutics, Inc.
Figure Sales and Growth Rate Analysis of Barrier Therapeutics, Inc.
Figure Revenue and Market Share Analysis of Barrier Therapeutics, Inc.
Table Product and Service Introduction of Barrier Therapeutics, Inc.
Table Company Profile and Development Status of Novartis Pharmaceuticals Corporation
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis Pharmaceuticals Corporation
Figure Sales and Growth Rate Analysis of Novartis Pharmaceuticals Corporation
Figure Revenue and Market Share Analysis of Novartis Pharmaceuticals Corporation
Table Product and Service Introduction of Novartis Pharmaceuticals Corporation
Table Company Profile and Development Status of Genentech, Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech, Inc
Figure Sales and Growth Rate Analysis of Genentech, Inc
Figure Revenue and Market Share Analysis of Genentech, Inc
Table Product and Service Introduction of Genentech, Inc
Table Company Profile and Development Status of Bristol-Myers Squibb
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
Table Product and Service Introduction of Bristol-Myers Squibb
-
